Irinotecan liposomal (II)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Irinotecan liposomal (II), covering 2025-01-09 to 2025-01-09. Get the full timeline:
Most recent: Clinical Trial Update: Adebrelimab Combined With Irinotecan Liposomal (II), Oxaliplatin, and 5-FU/LV Conversion Therapy for Locally Advanced Pancreatic Cancer [Phase 2]